These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Stability of [D-Trp11]-neurotensin to rat brain peptidases. McDermott JR; Gibson AM; Biggins JA Neurosci Lett; 1986 Dec; 72(1):79-83. PubMed ID: 3543750 [TBL] [Abstract][Full Text] [Related]
9. Ketomethylene and (cyanomethylene)amino pseudopeptide analogues of the C-terminal hexapeptide of neurotensin. González-Muñiz R; García-López MT; Gómez-Monterrey I; Herranz R; Jimeno ML; Suárez-Gea ML; Johansen NL; Madsen K; Thøgersen H; Suzdak P J Med Chem; 1995 Mar; 38(6):1015-21. PubMed ID: 7699693 [TBL] [Abstract][Full Text] [Related]
10. Mast cell binding of neurotensin. II. Molecular conformation of neurotensin involved in the stereospecific binding to mast cell receptor sites. Lazarus LH; Perrin MH; Brown MR; Rivier JE J Biol Chem; 1977 Oct; 252(20):7180-3. PubMed ID: 198404 [TBL] [Abstract][Full Text] [Related]
11. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors. Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier. Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036 [TBL] [Abstract][Full Text] [Related]
13. Functional activity of new C-terminal cyclic-neurotensin fragment analogs. Akunne HC; Darling S; Zoski K; Sefler AM; He JX; Sawyer TK; Pugsley TA; Cody WL Neuropeptides; 1996 Jun; 30(3):213-8. PubMed ID: 8819144 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysine. Lundquist JT; Dix TA J Med Chem; 1999 Nov; 42(23):4914-8. PubMed ID: 10579853 [TBL] [Abstract][Full Text] [Related]
15. Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogs. Lundquist JT; Büllesbach EE; Golden PL; Dix TA J Pept Res; 2002 Feb; 59(2):55-61. PubMed ID: 11906607 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities. Lundquist JT; Büllesbach EE; Dix TA Bioorg Med Chem Lett; 2000 Mar; 10(5):453-5. PubMed ID: 10743946 [TBL] [Abstract][Full Text] [Related]
17. Histamine release by neurotensin in the rat hindquarter: structure-activity studies. Kerouac R; St-Pierre S; Rioux F Peptides; 1984; 5(4):695-9. PubMed ID: 6208534 [TBL] [Abstract][Full Text] [Related]
18. Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues. Lundquist JT; Dix TA Bioorg Med Chem Lett; 1999 Sep; 9(17):2579-82. PubMed ID: 10498212 [TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574 [TBL] [Abstract][Full Text] [Related]
20. Binding chemistry and molecular heterogeneity of neurotensin binding protein(s)/receptor in adult chicken tissues. Mitra SP Indian J Biochem Biophys; 2013 Dec; 50(6):511-20. PubMed ID: 24772976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]